BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 150 filers reported holding BIONTECH SE in Q3 2020. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,844,211 | +0.7% | 4,518,080 | 0.0% | 2.92% | +3.4% |
| Q2 2023 | $487,636,374 | -10.6% | 4,518,080 | +3.2% | 2.82% | -12.7% |
| Q1 2023 | $545,370,201 | -17.1% | 4,378,022 | 0.0% | 3.24% | -15.8% |
| Q4 2022 | $657,666,465 | +11.4% | 4,378,022 | 0.0% | 3.84% | +8.7% |
| Q3 2022 | $590,507,607 | +636.6% | 4,378,022 | +714.3% | 3.54% | +705.2% |
| Q2 2022 | $80,161,229 | -12.6% | 537,634 | 0.0% | 0.44% | +13.7% |
| Q1 2022 | $91,698,855 | -33.8% | 537,634 | 0.0% | 0.39% | -22.8% |
| Q4 2021 | $138,602,000 | -5.6% | 537,634 | 0.0% | 0.50% | -2.5% |
| Q3 2021 | $146,769,000 | +21.9% | 537,634 | 0.0% | 0.51% | +27.3% |
| Q2 2021 | $120,365,000 | +105.0% | 537,634 | 0.0% | 0.40% | +75.2% |
| Q1 2021 | $58,704,000 | +33.9% | 537,634 | 0.0% | 0.23% | +22.3% |
| Q4 2020 | $43,828,000 | +17.8% | 537,634 | 0.0% | 0.19% | -0.5% |
| Q3 2020 | $37,220,000 | – | 537,634 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |